1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. DIAMEDICA THERAPEUTICS INC
DiaMedica Therapeutics Inc XNAS: DMAC

DiaMedica Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing treatment for ischemic diseases with two main clinical programs focused on acute ischemic stroke (AIS) and preeclampsia (PE). Its main prod...

Read More
7.04 -0.20 (-2.76%)
32.44% Fall from 52W High
40,886.5
XNAS Volume

XNAS 13 Mar, 2026 10:49 AM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for DiaMedica Therapeutics Inc is on 18 Mar 2026 for the purpose of DiaMedica Therapeutics Inc Fourth Quarter Earnings Results for 2025 See details
Durability score
Not Eligible
Valuation Score
Expensive Valuation
3.3 / 100
Momentum Score
Technically Neutral
47.5 / 100
Analyst Price Target
No estimates available

5

S

9

W

3

O

3

T

SWOT Analysis

DiaMedica Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..